T. Rowe Price Investment Management, Inc. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Applied Therapeutics, Inc. APLT | T. Rowe Price Investment Management, Inc. | 21,403,300 14.900% | 2,719,310 (+14.55%) | Filing |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | Applied Therapeutics, Inc. APLT | T. Rowe Price Investment Management, Inc. | 18,683,990 13.200% | 3,071,404 (+19.67%) | Filing |
| 2025-05-07 10:37 am Purchase | 2025-04-30 | 13G | Applied Therapeutics, Inc. APLT | T. Rowe Price Investment Management, Inc. | 15,612,586 11.000% | 5,231,996 (+50.40%) | Filing |
| 2025-05-07 10:19 am Purchase | 2025-03-31 | 13G | Applied Therapeutics, Inc. APLT | T. Rowe Price Investment Management, Inc. | 10,380,590 8.900% | 10,380,590 (New Position) | Filing |